Tag Archives: RRMS

May, 2017

January, 2016

  • 13 January

    The MS Game Changer

    A new medication for multiple sclerosis made waves when research about its effectiveness debuted at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) back in October 2015. Now experts are calling this medication one of the greatest developments of the past year for the …

  • 4 January

    Teva and Active Biotech Discontinue Trials Evaluating Higher Doses of Oral MS Drug

    JERUSALEM & LUND, Sweden–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Active Biotech (NASDAQ Stockholm:ACTI) today announced the discontinuation of higher doses of laquinimod in two ongoing studies in multiple sclerosis after the occurrence of cardiovascular events, none of which was fatal, in eight patients. The change comes …

December, 2015